MCID: INT053
MIFTS: 37

Intracranial Vasospasm

Categories: Cardiovascular diseases, Neuronal diseases

Aliases & Classifications for Intracranial Vasospasm

MalaCards integrated aliases for Intracranial Vasospasm:

Name: Intracranial Vasospasm 12 15 17
Vasospasm, Intracranial 44 70

Classifications:



External Ids:

Disease Ontology 12 DOID:13100
MeSH 44 D020301
UMLS 70 C0751895

Summaries for Intracranial Vasospasm

MalaCards based summary : Intracranial Vasospasm, also known as vasospasm, intracranial, is related to migraine with aura and migraine with or without aura 1. An important gene associated with Intracranial Vasospasm is S100B (S100 Calcium Binding Protein B), and among its related pathways/superpathways are Peptide ligand-binding receptors and Neuroscience. The drugs Milrinone and Nicardipine have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and kidney, and related phenotypes are behavior/neurological and homeostasis/metabolism

Related Diseases for Intracranial Vasospasm

Diseases related to Intracranial Vasospasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 167)
# Related Disease Score Top Affiliating Genes
1 migraine with aura 28.5 VIP TAC1 MTR MTHFR F2 ACE
2 migraine with or without aura 1 27.6 VIP TAC1 S100B OXT NPY MTHFR
3 traumatic brain injury 10.4 S100B APOE
4 head injury 10.4 S100B APOE
5 mitochondrial dna-associated leigh syndrome 10.3 MT-ND5 MT-ATP6
6 mitochondrial dna-associated leigh syndrome and narp 10.3 MT-ND5 MT-ATP6
7 thelaziasis 10.3 MT-ND5 MT-ATP6
8 dicrocoeliasis 10.3 MT-ND5 MT-ATP6
9 neurogenic bowel 10.3 VIP TAC1
10 anismus 10.3 VIP TAC1
11 baylisascariasis 10.3 MT-ND5 MT-ATP6
12 breath-holding spells 10.3 S100B NPY
13 binswanger's disease 10.3 VIP APOE
14 mitochondrial myopathy, infantile, transient 10.2 MT-ND5 MT-ATP6
15 endometrial small cell carcinoma 10.2 VIP TAC1
16 moderate and severe traumatic brain injury 10.2 APOE ACE
17 splenic sequestration 10.2 HP F2
18 hemiplegia 10.2 TAC1 S100B MT-ATP6
19 somatization disorder 10.2 TAC1 OXT
20 facial dermatosis 10.2 VIP TAC1
21 bladder neck obstruction 10.2 TAC1 ACE
22 generalized atherosclerosis 10.2 APOE ACE
23 subleukemic leukemia 10.2 S100B OXT
24 asphyxia neonatorum 10.2 S100B OXT
25 intestinal pseudo-obstruction 10.2 VIP S100B EDN3
26 supine hypotensive syndrome 10.2 OXT F2
27 leprosy 2 10.2 VIP NPY
28 posterior urethral valves 10.1 AGTR2 ACE
29 amnestic disorder 10.1 S100B OXT APOE
30 hepatoportal sclerosis 10.1 F2 ACE
31 pneumoconiosis due to talc 10.1 F2 ACE
32 placenta praevia 10.1 OXT F2
33 interval angle-closure glaucoma 10.1 TAC1 KNG1
34 pyridoxine deficiency anemia 10.1 F2 ACE
35 algoneurodystrophy 10.1 TAC1 KNG1
36 intracranial berry aneurysm 10.1 S100B HP EDN3 APOE
37 vaginal discharge 10.1 OXT HP
38 patella, chondromalacia of 10.1 S100B ACE
39 myofascial pain syndrome 10.1 TAC1 KNG1
40 cholesterol embolism 10.1 F2 ACE
41 acute mountain sickness 10.1 S100B ACE
42 hypertensive encephalopathy 10.1 F2 ACE
43 idiopathic nephrotic syndrome 10.1 APOE ACE
44 intracranial embolism 10.1 F2 ACE
45 akinetopsia 10.1 TAC1 KNG1
46 paralytic ileus 10.1 VIP TAC1 F2
47 bursitis 10.1 TAC1 KNG1
48 ganglioneuroblastoma 10.0 VIP S100B NPY
49 sleep apnea 10.0 TAC1 APOE ACE
50 functional gastric disease 10.0 VIP TAC1

Graphical network of the top 20 diseases related to Intracranial Vasospasm:



Diseases related to Intracranial Vasospasm

Symptoms & Phenotypes for Intracranial Vasospasm

MGI Mouse Phenotypes related to Intracranial Vasospasm:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10 ACE AGTR2 APOE EDN3 F2 KNG1
2 homeostasis/metabolism MP:0005376 9.93 ACE AGTR2 APOE F2 HP KNG1
3 integument MP:0010771 9.56 AGTR2 APOE EDN3 F2 MTHFR OXT
4 renal/urinary system MP:0005367 9.17 ACE AGTR2 APOE HP NPY OXT

Drugs & Therapeutics for Intracranial Vasospasm

Drugs for Intracranial Vasospasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 75)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Milrinone Approved Phase 4 78415-72-2 4197
2
Nicardipine Approved, Investigational Phase 4 55985-32-5 4474
3
Verapamil Approved Phase 4 52-53-9 2520
4
Nitroglycerin Approved, Investigational Phase 4 55-63-0 4510
5 Omega 3 Fatty Acid Phase 4
6 Eicosapentaenoic acid ethyl ester Phase 4
7 Anti-Arrhythmia Agents Phase 4
8 Vasodilator Agents Phase 4
9 Calcium, Dietary Phase 4
10 Antihypertensive Agents Phase 4
11 Hormones Phase 4
12 calcium channel blockers Phase 4
13
Calcium Nutraceutical Phase 4 7440-70-2 271
14
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 2, Phase 3 7487-88-9 24083
15 Anesthetics Phase 2, Phase 3
16 Analgesics Phase 2, Phase 3
17 Anticonvulsants Phase 2, Phase 3
18 Tocolytic Agents Phase 2, Phase 3
19
tannic acid Approved Phase 1, Phase 2 1401-55-4
20
Benzocaine Approved, Investigational Phase 1, Phase 2 1994-09-7, 94-09-7 2337
21
Clevidipine Approved, Investigational Phase 2 167221-71-8
22
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 2 437-38-7 3345
23
Dexmedetomidine Approved, Vet_approved Phase 2 113775-47-6 68602 5311068
24
Midazolam Approved, Illicit Phase 2 59467-70-8 4192
25
Mannitol Approved, Investigational Phase 1, Phase 2 69-65-8 453 6251
26
Dantrolene Approved, Investigational Phase 1, Phase 2 7261-97-4 2952 6914273
27
Heparin Approved, Investigational Phase 2 9005-49-6 772 9812414
28
Bupivacaine Approved, Investigational Phase 2 38396-39-3, 2180-92-9 2474
29
Clonidine Approved Phase 2 4205-90-7 2803
30 Analgesics, Non-Narcotic Phase 2
31 Psychotropic Drugs Phase 2
32 Hypnotics and Sedatives Phase 2
33 Narcotics Phase 2
34 Anesthetics, General Phase 2
35 Anesthetics, Intravenous Phase 2
36 GABA Modulators Phase 2
37 Anti-Anxiety Agents Phase 2
38 Analgesics, Opioid Phase 2
39
Glycopyrrolate Phase 2 596-51-0 3494
40 diuretics Phase 1, Phase 2
41 calcium heparin Phase 2
42 Platelet Aggregation Inhibitors Phase 2
43 Cardiotonic Agents Phase 2
44 Phosphodiesterase 3 Inhibitors Phase 2
45 Protective Agents Phase 2
46 Pharmaceutical Solutions Phase 2
47 Anesthetics, Local Phase 2
48 Adrenergic alpha-Agonists Phase 2
49 Adrenergic Agonists Phase 2
50 Neurotransmitter Agents Phase 2

Interventional clinical trials:

(show top 50) (show all 61)
# Name Status NCT ID Phase Drugs
1 The Role of Statins in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage Unknown status NCT01346748 Phase 4 statin
2 Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study (EVAS): Effect of Eicosapentaenoic Acid on Cerebral Vasospasm Following Subarachnoid Hemorrhage Completed NCT00839449 Phase 4 Eicosapentaenoic acid ethyl ester
3 The Intra-arterial Vasospasm Trial(iVAST)- A Multi-center Randomized Study Recruiting NCT01996436 Phase 4 Nicardipine;Verapamil;Nicardipine + Verapamil + Nitroglycerin
4 Magnesium in Treating Subarachnoid Hemorrhage Related Vasospasm, A Haptoglobin Genomic Based Randomized Controlled Trial Not yet recruiting NCT04613960 Phase 2, Phase 3 Magnesium sulfate;normal saline
5 Prevention of Secondary Ischemia After Aneurysmal Subarachnoid Hemorrhage With Cerebrospinal Fluid Drainage. A Randomized Controlled Trial Terminated NCT01407614 Phase 2, Phase 3
6 Hypertonic Saline Solution in Aneurysmal Subarachnoid Hemorrhage: A Randomized - Phase II Single Blinded Clinical Trial Unknown status NCT02432157 Phase 1, Phase 2 HTS 3%;Standard fluid management
7 Clevidipine for Vasospasm After Subarachnoid Hemorrhage Unknown status NCT02011321 Phase 2 clevidipine
8 A Randomized, Controlled Trial on Dexmedetomidine for Providing Adequate Sedation and Preserved Neurologic Examination for Endovascular Treatment of Acute Ischemic Stroke or Cerebral Vasospasm. Unknown status NCT01845441 Phase 2 Dexmedetomidine;Fentanyl;Midazolam
9 A Prospective, Multi-center, Open-label, Single-arm, Phase 2 Study to Assess the Efficacy and Safety of Clazosentan in Reversing Angiographically-confirmed Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage (aSAH) Treated by Surgical Clipping or Endovascular Coiling Completed NCT02560532 Phase 2 Clazosentan
10 Dantrolene in the Prevention and Treatment of Cerebral Vasospasm in Subarachnoid Hemorrhage Completed NCT01024972 Phase 1, Phase 2 Dantrolene;Placebo
11 Dantrolene in the Treatment of Cerebral Vasospasm After Subarachnoid Hemorrhage - a Phase 1 Study Completed NCT00964548 Phase 1, Phase 2 Dantrolene;Dantrolene
12 A Phase IIb, Multi-center, International, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding Study for the Prevention of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage (aSAH) by Intravenous Administration of Clazosentan, a Selective Endothelin A (ETA) Receptor Antagonist Completed NCT00111085 Phase 2 Clazosentan 1 mg/h;Clazosentan 5 mg/h;Clazosentan 15 mg/h;Placebo
13 Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial Completed NCT03318783 Phase 1, Phase 2 GSK2256294;Placebo
14 A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients With Significant Hemorrhage Burden Recruiting NCT02501434 Phase 2 Continuous Low-Dose IV Unfractionated Heparin Infusion
15 Safety and Efficacy of Cervical Sympathetic Block in Patients With Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage - Pilot Study Terminated NCT00930072 Phase 2 Cervical Sympathetic Block (bupivicaine, clonidine)
16 Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Terminated NCT02712788 Phase 2 Milrinone;Placebo
17 Intraventricular Nicardipine for the Treatment of Cerebral Vasospasm: Prospective Pilot Study Terminated NCT01810302 Phase 2 Nicardipine hydrochloride;Preservative-free normal saline
18 Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm Terminated NCT02176837 Phase 2 Sodium Nitrite
19 Sildenafil for Prevention of Cerebral Vasospasm Secondary to Subarachnoid Haemorrhage - Phase II Randomized Clinical Trial Withdrawn NCT01091870 Phase 2 Placebo;Sildenafil Citrate, 25 mg, 3 times a day.;Sildenafil Citrate 50 mg, 3 times a day
20 Safety and Efficacy Trial of Sildenafil Citrate in Attenuation of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Withdrawn NCT00871065 Phase 2 Sildenafil citrate
21 Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage Withdrawn NCT01878136 Phase 1, Phase 2 Tissue Plasminogen Activator
22 Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Using MTS Trial System 3510 Completed NCT00766844 Phase 1
23 Efficacy Of Ultrasound Guided Stellate Ganglion Block To Relieve Vasospasm Following Clipping Of Cerebral Aneurysm Completed NCT02775318 Phase 1 Bupivacaine
24 Prophylactic Remote Ischemic Preconditioning for Cerebral Vasospasm Following Subarachnoid Hemorrhage Completed NCT01158508 Phase 1
25 Sildenafil for the Treatment of Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage Active, not recruiting NCT03028298 Phase 1 Low dose sildenafil citrate;High dose sildenafil citrate
26 An Evaluation of Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm Unknown status NCT02704637
27 Lumenate Observational Vasospasm Interventional Trial (LOVIT) Unknown status NCT03511040
28 The Factors Cause Vasospasm After Aneurysmal Subarachnoid Hemorrhage Unknown status NCT00745758
29 An Open-Label, Non-Randomized, Comparative Study Designed to Evaluate the Accuracy and Safety of HS-1000 Device, a Non-Invasive Brain Monitor Unknown status NCT02775136
30 Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage Unknown status NCT01400360
31 Safety and Performance of the Delta System in the Treatment of Vasospasm in Aneurysmal Subarachnoid Hemorrhage (aSAH) Patients Unknown status NCT02129413
32 CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage Unknown status NCT02056769
33 Therapeutic Hypercapnia After Aneurysmal Subarachnoid Hemorrhage - Study for the Optimum Duration of Hypercapnia Completed NCT04687605
34 Predictive Value of Mean Flow Velocity by TCD in Early Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Completed NCT04329208
35 A Non-Randomized, Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM System to Transcranial Doppler as an Aid to Diagnosing Vasospasm Completed NCT01595802
36 Clinical Implication of Prolonged Vasospasm in Subarachnoid Hemorrhage Completed NCT04193124
37 Study of Quality of Life After Aneurysmal Subarachnoid Hemorrhage in Patients Aged 70 Years or Older. Completed NCT00692744
38 Evaluation of the Efficacy of Transcutaneous Trigeminal Nerve Stimulation for Prevention of Cerebral Vasospasm and Its Consequences After Subarachnoid Haemorrhage Due to Ruptured Aneurysm: a Multicentre, Randomized, Double-blind Study Completed NCT02482883
39 Computed Tomographic Perfusion and Computed Tomographic Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage Completed NCT00962546
40 Real Time Monitoring for Cerebral Vasospasm Using Bilateral Processed Electroencephalogram (EEG) Completed NCT01187420
41 The Efficacy and Safety of Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage Completed NCT02275949
42 Identification of Novel Molecular Markers for Vasospasm From the Cerebrospinal Fluid (CSF) of Patients With Aneurysmal Subarachnoid Hemorrhage Completed NCT02389634
43 Cerebral Aneurysms: a Retrospective Study on the Experience in Our Hospital With a Comparative Analysis Between the Different Techniques Used in Its Treatment Completed NCT04792944 Urokinase
44 Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage Completed NCT01799018
45 Role of Computed Tomography Perfusion in Detection of Patients at Risk for Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Completed NCT03214705
46 Lumbar Drainage Compared With Extraventricular Drainage of Cerebral Spinal Fluid in Treatment of Patients With Subarachnoid Hemorrhage - a Prospective Randomized Controlled Trial Recruiting NCT03065231
47 Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm Recruiting NCT03517670
48 The Vesalio Neva VS for the Treatment of Symptomatic Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage (aSAH) (The VITAL Study) Recruiting NCT03611790
49 C-arm Cone Beam CTA and CTP With Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage: Evaluating Predictability for Early Ischemia in Cerebral Vasospasm Recruiting NCT03377049
50 Inter- and Intra-Observer Variability in Transcranial Doppler (TCD) Technique in Neurocritical Care Patients Recruiting NCT04583163

Search NIH Clinical Center for Intracranial Vasospasm

Cochrane evidence based reviews: vasospasm, intracranial

Genetic Tests for Intracranial Vasospasm

Anatomical Context for Intracranial Vasospasm

MalaCards organs/tissues related to Intracranial Vasospasm:

40
Brain, Spinal Cord, Kidney, Heart, Placenta, Liver, Skin

Publications for Intracranial Vasospasm

Articles related to Intracranial Vasospasm:

(show all 50)
# Title Authors PMID Year
1
Ruptured Spinal Aneurysms: Diagnosis and Management Paradigms. 61
33223127 2021
2
Use of stent retriever for treatment of iatrogenic intracranial vasospasm. 61
31088245 2019
3
Vasospasm as a major complication after acute mechanical thrombectomy with stent retrievers. 61
30904242 2019
4
Migrainous Infarction And Cerebral Vasospasm: Case Report And Literature Review. 61
31695483 2019
5
Extracranial internal carotid artery vasospasm during thrombectomy. 61
28895453 2018
6
Delayed Vasospasm after Aneurysmal Subarachnoid Hemorrhage in Behcet Syndrome. 61
27114963 2016
7
Intracranial Vasospasm without Intracranial Hemorrhage due to Acute Spontaneous Spinal Subdural Hematoma. 61
26713084 2015
8
Role of Genetic Polymorphisms in Predicting Delayed Cerebral Ischemia and Radiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis. 61
26074429 2015
9
Treatment of intracranial vasospasm following subarachnoid hemorrhage. 61
24904517 2014
10
Safety of early endovascular catheterization and intervention through extracranial-intracranial bypass grafts. 61
21942723 2012
11
Percutaneous transluminal angioplasty in a patient with vasospasm secondary to coccidioidal meningitis: case report and review of the literature. 61
21990792 2011
12
Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article. 61
19877802 2010
13
Intracranial vasospasm with delayed ischaemic deficit following epidermoid cyst resection. 61
20603397 2010
14
[Aneurysmal subarachonid haemorrhage]. 61
20533231 2010
15
Intracranial vasospasm with subsequent stroke after traumatic subarachnoid hemorrhage in a 22-month-old child. 61
19338410 2009
16
Anesthetic considerations of selective intra-arterial nicardipine injection for intracranial vasospasm: a case series. 61
17413999 2007
17
Clinical utility of multislice computed tomographic angiography for detection of cerebral vasospasm in acute subarachnoid hemorrhage. 61
17163342 2006
18
Delayed intracranial vasospasm following carotid endarterectomy. 61
16088117 2005
19
[Reversible posterior leukoencephalopathy syndrome: experience in 3 cases]. 61
15729881 2004
20
Successful treatment of cerebral vasospasm by use of transdermal nitroglycerin ointment (Nitropaste). 61
12812961 2003
21
[Clinical use of transcranial Doppler in critical neurological patients. Results of a multicenter study]. 61
12622997 2003
22
Cerebral angiography in the rat with mammographic equipment: a simple, cost-effective method for assessing vasospasm in experimental subarachnoid haemorrhage. 61
12185547 2002
23
Symptomatic vasospasm after subarachnoid haemorrhage: assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography. 61
12136364 2002
24
[Transcranial Doppler imaging: state of the art]. 61
11507445 2001
25
Vasospasm after subarachnoid hemorrhage: diagnosis with MR angiography. 61
11039339 2000
26
Intracranial angioplasty and thrombolysis. 61
10565870 2000
27
Transcranial color-coded duplex sonography. 61
10460438 1999
28
Nonaneurysmal thunderclap headache with diffuse, multifocal, segmental, and reversible vasospasm. 61
10214538 1999
29
Cerebrovascular ultrasound. 61
10097886 1999
30
Diffuse cerebral vasospasm with ischemia after resection of a cerebellopontine angle primitive neuroectodermal tumor in a child. 61
9973676 1998
31
Three-dimensional CT angiography of intracranial vasospasm following subarachnoid haemorrhage. 61
9833891 1998
32
Suppression of HIV-1 replication in peripheral blood mononuclear cells by fasudil. 61
9597811 1998
33
CT angiography of cerebral vasospasm with conventional angiographic comparison. 61
9111662 1997
34
MR angiography of cerebral vasospasm in preeclampsia. 61
7677037 1995
35
Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan. 61
7560482 1995
36
Severe diffuse intracranial vasospasm as a cause of extensive migrainous cerebral infarction. 61
8374945 1993
37
Role of transcranial Doppler in neuroradiological treatment of intracranial vasospasm. 61
8421832 1993
38
Effects of dobutamine and dopamine on whole brain blood flow and metabolism in unanesthetized monkeys. 61
15815473 1992
39
Intraarterial papaverine for relief of catheter-induced intracranial vasospasm. 61
1546611 1992
40
Cerebral vasospasm evaluated by transcranial Doppler ultrasonography at different intracranial pressures. 61
1919698 1991
41
[Management of intracranial vasospasm in rupture of cerebral aneurysm]. 61
1811186 1991
42
[A model for intracranial vasospasm in subarachnoid hemorrhage]. 61
2017293 1991
43
Migrainous stroke. 61
3337678 1988
44
[Relief of experimental cerebral vasospasm by the intrathecal administration of a calcium antagonist (diltiazem)--in comparison with intra-arterial administration]. 61
3840580 1985
45
Early aneurysm operation and vasospasm. Intracranial Doppler findings. 61
3892347 1985
46
Bilateral cervical carotid and intracranial vasospasm causing cerebral ischemia in a migrainous patient: a case of "diplegic migraine". 61
6490360 1984
47
[Traumatic intraclinoidal aneurysm of the internal carotid artery]. 61
7123690 1982
48
Intracranial vasospasm: a study with iron compounds. 61
35848 1979
49
Vasoconstriction of external carotid arteries after rupture of intracranial aneurysms. 61
517197 1979
50
The relief of intracranial vasospasm: an experimental study with methylprednisolone and cortisol. 61
806982 1975

Variations for Intracranial Vasospasm

Expression for Intracranial Vasospasm

Search GEO for disease gene expression data for Intracranial Vasospasm.

Pathways for Intracranial Vasospasm

GO Terms for Intracranial Vasospasm

Cellular components related to Intracranial Vasospasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.65 TAC1 S100B OXT NPY KNG1 HP
2 blood microparticle GO:0072562 9.46 KNG1 HP F2 APOE
3 extracellular region GO:0005576 9.36 VIP TAC1 S100B OXT NPY KNG1
4 endocytic vesicle lumen GO:0071682 9.26 HP APOE

Biological processes related to Intracranial Vasospasm according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of cell proliferation GO:0008284 9.8 VIP S100B F2 EDN3 AGTR2
2 positive regulation of blood vessel diameter GO:0097755 9.54 VIP AGTR2
3 nitric oxide mediated signal transduction GO:0007263 9.52 APOE AGTR2
4 blood coagulation, intrinsic pathway GO:0007597 9.51 KNG1 F2
5 positive regulation of ossification GO:0045778 9.49 TAC1 OXT
6 negative regulation of blood coagulation GO:0030195 9.48 KNG1 APOE
7 negative regulation of heart rate GO:0010459 9.46 TAC1 AGTR2
8 methionine biosynthetic process GO:0009086 9.43 MTR MTHFR
9 vasodilation GO:0042311 9.43 KNG1 APOE AGTR2
10 negative regulation of platelet activation GO:0010544 9.37 F2 APOE
11 positive regulation of renal sodium excretion GO:0035815 9.33 TAC1 OXT AGTR2
12 positive regulation of penile erection GO:0060406 9.32 VIP OXT
13 G protein-coupled receptor signaling pathway GO:0007186 9.28 VIP TAC1 OXT NPY KNG1 F2
14 regulation of blood pressure GO:0008217 9.26 TAC1 NPY AGTR2 ACE

Molecular functions related to Intracranial Vasospasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 9.55 NPY KNG1 F2 EDN3 APOE
2 neuropeptide hormone activity GO:0005184 9.13 VIP OXT NPY
3 hormone activity GO:0005179 8.92 VIP OXT NPY EDN3

Sources for Intracranial Vasospasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 20-May-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....